Program record · Telehealth · membership plus per-medication charge
Fem Excel charges a $99 monthly membership plus medication billed every two months from $50 a month, so estradiol alone comes to $149 a month. A first-month-free promotion is advertised and is not used as the price.
2 offers · Source read Oct 23, 2026
Read from the provider's own pricing page · standard rate, no promotional pricing.
One row per offer. The charge stays as billed, and the monthly equivalent is derived and labeled as derived.
Estradiol
Form not stated
Billed together: $149.00 first month + $99.00 consultation and test kit.
Estradiol with progesterone
Form not stated
Billed together: $199.00 first month + $99.00 consultation and test kit.
How the billing works
The $99 membership recurs monthly. Medication is billed every two months at $50 a month for each medicine. The first month of membership is advertised as free, which is a promotion and is not reflected in the recorded rate.
Where the record stops
The membership and the medication charge run on different cadences, monthly and every two months, and both recur. Two offers are recorded because the total depends on how many medicines are prescribed, and the single-medication figure is not presented as the cost of a two-medication plan.
Sourcing
Published in full rather than collapsed. A record is only as citable as the rows behind it, including the rows that establish nothing.
9 source rows · every row dated
Membership charge
Reported$99 a month for ongoing provider access and clinical management. The first month is advertised as free, which is a promotion and is not used as the rate.
femexcel.comRead Oct 23, 2026
Medication charge
ReportedFrom $50 a month per medication, billed every two months, separate from the membership.
femexcel.comRead Oct 23, 2026
Consultation and test kit
Reported$99 once, in the first billing cycle.
Provider pricing pageRead Oct 23, 2026
Refunds
Sources conflictThe terms state that all sales are final and membership fees are non-refundable in whole or in part. The homepage and FAQ promise a membership refund where there are no results after 90 days. The record states both and resolves neither.
femexcel.com/terms-conditions/Read Oct 23, 2026
Operator
ReportedThe terms name Male Excel Inc., doing business as Excel Medical. Fem Excel is a brand name. An earlier review naming a different parent company is not supported by the provider's own pages.
femexcel.com/terms-conditions/Read Oct 23, 2026
Formulation
Not establishedMedication is described as bioidentical and compounded, and progesterone tablets and thyroid capsules appear in captions. A specific estradiol formulation is not published, so the field stays unstated.
femexcel.com/faqs/Read Oct 23, 2026
Monthly total
Reported$99 membership plus $50 for estradiol and $50 for progesterone, so $199 a month.
femexcel.comRead Oct 23, 2026
Medication charge
ReportedEach medication is billed at $50 a month, so the total rises with the number prescribed.
Provider pricing pageRead Oct 23, 2026
Refunds
Sources conflictThe terms and the marketing pages disagree on whether the membership is refundable. Both positions are recorded.
femexcel.com/terms-conditions/Read Oct 23, 2026
A field with no published answer reads not established. It is never shown as a dash, because a dash is where a zero usually hides.
Billed with Estradiol and Progesterone inside one offer.
Available in every state except Alaska, Arkansas, Connecticut, Hawaii, Idaho, Louisiana, Mississippi, New Hampshire and Rhode Island.
Commitment, cancellation and refund wording above is quoted as Fem Excel published it on Oct 23, 2026. It is not a statement of a legal entitlement: auto-renewal and cancellation rules differ by state, and the provider can change its terms after that date.
Nothing here is medical advice. Whether a treatment is appropriate is a decision for a licensed clinician. These terms describe a payment, not whether a treatment is appropriate for anyone.
How this is funded
No program pays for a position here, and no outbound link carries a referral commission. That is a flag in the data rather than a sentence in the copy: if either ever changes, every page that shows this notice discloses it automatically.
Score
The published total is out of 100, but 75 of those points are the same for every listed record. They are the inclusion baseline, not something this program earned. The informative figure is the detail points on top of that baseline, out of 25, earned across five published components: price level, price completeness, required fees priced, terms on record, and whether dose and coverage are stated. It measures how completely the charges are published, not clinical quality, effectiveness, safety or medical endorsement, and no editorial mark is applied.
Disclosure detail earned
20.4of 25
75 of the 95.4 is the fixed inclusion baseline shared by every listed record. The remaining 20.4 is what this record earned on the five components below.
The five components that earn those 25 points
The lowest all-in monthly equivalent the record can derive. Full marks at or below $75, none at or above $400, linear between. No marks at all where the all-in figure is withheld.
The share of a program's offers that carry a derivable all-in monthly figure. The heaviest single weight, because a published all-in price for every offer sold is the thing this index measures.
The share of a program's offers where no required consultation, lab, membership or startup fee is left without an amount.
Two for stating that there is no minimum term, one for stated cancellation terms, one for a membership stated as a number. A stated lock-in earns nothing here.
One for stating whether the charge varies by dose, one for recording where the program ships.
This score measures pricing disclosure completeness. It is not a measure of clinical quality, effectiveness or safety, and it is not a medical endorsement of any program.
Labs included
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Follow-ups included
The sources read establish the opposite of this statement at the check date.
Checked Oct 23, 2026
No separate membership
The sources read establish the opposite of this statement at the check date.
Checked Oct 23, 2026
Flat across dose
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Month to month
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Compounded available
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
FDA-approved only
The sources read do not settle this either way, so it is recorded as not verified rather than as a miss.
Checked Oct 23, 2026
Ships to all 50 states
The sources read establish the opposite of this statement at the check date.
Checked Oct 23, 2026
Each line records what the sources established on the check date. A verified line is a finding, a verified-not-met line is the opposite finding, and a not-verified line means the source did not say. A criterion is not a ranking and not a mark of quality.
Last modified Oct 23, 2026